0002085969-25-000001.txt : 20250917 0002085969-25-000001.hdr.sgml : 20250917 20250917084209 ACCESSION NUMBER: 0002085969-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250917 DATE AS OF CHANGE: 20250917 EFFECTIVENESS DATE: 20250917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SiVEC Biotechnologies, Inc. CENTRAL INDEX KEY: 0002085969 ORGANIZATION NAME: EIN: 812232432 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-557746 FILM NUMBER: 251318844 BUSINESS ADDRESS: STREET 1: 1505 WEST MULBERRY STREET CITY: FORT COLLINS STATE: CO ZIP: 80521 BUSINESS PHONE: 970.310.7967 MAIL ADDRESS: STREET 1: 1505 WEST MULBERRY STREET CITY: FORT COLLINS STATE: CO ZIP: 80521 D 1 primary_doc.xml X0708 D LIVE 0002085969 SiVEC Biotechnologies, Inc. 1505 WEST MULBERRY STREET FORT COLLINS CO COLORADO 80521 970.310.7967 DELAWARE None None Corporation true 2022 Lyndsey Linke 1505 West Mulberry Street Fort Collins CO COLORADO 80521 Executive Officer Director Darcy Mora 1505 West Mulberry Street Fort Collins CO COLORADO 80521 Executive Officer Director Richard A. Freed III 1505 West Mulberry Street Fort Collins CO COLORADO 80521 Director Sibylle Hauser 1505 West Mulberry Street Fort Collins CO COLORADO 80521 Director David Sherris 1505 West Mulberry Street Fort Collins CO COLORADO 80521 Director Biotechnology Decline to Disclose 06b false 2025-08-28 false true false 0 5800000 3299994 2500006 In addition to the shares sold for cash, an aggerate of $304,069 in convertible notes converted into Issuer's preferred stock. false 3 0 0 0 false SiVEC Biotechnologies, Inc. Lyndsey Linke Lyndsey Linke Chief Executive Officer 2025-09-17